Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Sarepta Therapeutics Inc shares valued at $1,310,820 were sold by Wigzell Hans Lennart Rudolf on Dec 12 ’24. At $124.84 per share, Wigzell Hans Lennart Rudolf sold 10,500 shares. The insider’s holdings dropped to 22,840 shares worth approximately $2.45 million following the completion of this transaction.
Also, Wigzell Hans Lennart Rudolf purchased 10,500 shares, netting a total of over 1,310,400 in proceeds.
Before that, Boor Kathryn Jean had sold 1,636 shares from its account. In a trade valued at $205,400, the Director traded Sarepta Therapeutics Inc shares for $125.55 each. Upon closing the transaction, the insider’s holdings decreased to 1,636 shares, worth approximately $0.63 million.
As published in their initiating research note from Deutsche Bank on February 11, 2025, Sarepta Therapeutics Inc [SRPT] has been a Hold and the price target has been revised to $136. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in late November. As of November 25, 2024, H.C. Wainwright has initiated its “Sell” rating for SRPT. Earlier on November 07, 2024, Cantor Fitzgerald upgraded its rating. Their new recommendation was “an Overweight” for SRPT stock which previously was a “a Neutral”.
Analyzing SRPT Stock Performance
During the last five days, there has been a drop of approximately -2.33%. Over the course of the year, Sarepta Therapeutics Inc shares have dropped approximately -11.90%. Shares of the company reached a 52-week high of $129.84 on 01/07/25 and a 52-week low of $101.15 on 02/18/25. A 50-day SMA is recorded $119.00, while a 200-day SMA reached $128.31. Nevertheless, trading volume fell to 0.71 million shares from 1.31 million shares the previous day.
Support And Resistance Levels for Sarepta Therapeutics Inc (SRPT)
According to the 24-hour chart, there is a support level at 105.42, which, if violated, would cause prices to drop to 103.72. In the upper region, resistance lies at 108.14. The next price resistance is at 109.16. RSI (Relative Strength Index) is 35.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -4.70, which suggests the price will decrease in the coming days. Percent R is at 68.41%, indicating low price movement. Stochastics %K at buying indicates that the stock is to be held.
